177Lu/225Ac labeled alphavbeta3-integrin targeting peptidomimetics (Advanced Innovative Partners)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug Name177Lu/225Ac labeled alphavbeta3-integrin targeting peptidomimetics (Advanced Innovative Partners)

Drug Alias Nameintegrin alpha-v/beta-3 targeted PET imaging agents (Advanced Innovative Partners)integrin alpha-v/beta-3 targeted peptidomimetics (Advanced Innovative Partners)integrin alpha-v/beta-3 antagonists (Advanced Innovative Partners)

ClassificationSmall molecules > PeptidomimeticRadiation-emitting products

Mechanisms of ActionPositron-emission tomography enhancers

TargetsUpdating

Therapy Area/IndicationsSmall Cell Lung CarcinomaCarcinoma, Non-Small-Cell LungBreast Neoplasms +[5]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesIndia

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaN/A

Originator CompaniesAdvanced Innovative Partners Inc

China Registration ClassN/A

Develop Information

Active CompaniesAdvanced Innovative Partners Inc

Inactive CompaniesN/A

Active IndicationsSmall Cell Lung CarcinomaCarcinoma, Non-Small-Cell LungBreast Neoplasms +[4]

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A